COMPARISON OF REAL-WORLD SAFETY AND EFFECTIVENESS OF MEPOLIZUMAB AND BENRALIZUMAB IN THE MANAGEMENT OF SEVERE ASTHMA: A SYSTEMATIC REVIEW

被引:0
|
作者
Bhavanasai, S. [1 ]
Vullengala, N. [1 ]
Yarramsetti, P. [1 ]
Jan, R. [1 ]
Kaur, G. [1 ]
Udhayasri, R. [1 ]
Sodhi, B. [1 ]
Gomes, A. [1 ]
Dang, A. [1 ]
Dang, D. [1 ]
Vallish, B. N. [1 ]
机构
[1] MarksMan Healthcare Commun, Hyderabad, Telangana, India
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
RWD100
引用
收藏
页码:S523 / S523
页数:1
相关论文
共 50 条
  • [21] Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review
    Israel, Elliot
    Canonica, Giorgio Walter
    Brusselle, Guy
    Yang, Shibing
    Howarth, Peter H.
    Martin, Amber L.
    Koufopoulou, Maria
    Smith, Steven G.
    Alfonso-Cristancho, Rafael
    JOURNAL OF ASTHMA, 2022, 59 (11) : 2201 - 2217
  • [22] A Real-World Study to Evaluate the Effectiveness of Mepolizumab in Treating Severe Asthma in Taiwan (REMIT)
    Xu, X.
    Perng, D.
    Cheng, S.
    Lai, Y.
    Milea, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [23] Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic Asthma
    Kavanagh, Joanne E.
    d'Ancona, Grainne
    Elstad, Maria
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Roxas, Cris
    Dhariwal, Jaideep
    Nanzer, Alexandra M.
    Kent, Brian D.
    Jackson, David J.
    CHEST, 2020, 158 (02) : 491 - 500
  • [24] Effectiveness of mepolizumab in severe asthma in Japan: A real-world study using claims data
    Nagase, Hiroyuki
    Tamaoki, Jun
    Suzuki, Takeo
    Nezu, Yasuko
    Katsumata, Masayuki
    Komatsubara, Masaki
    Mu, George
    Yang, Shibing
    Cole, Ashley L.
    Alfonso-Cristancho, Rafael
    CLINICAL AND TRANSLATIONAL ALLERGY, 2021, 11 (08)
  • [25] A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT)
    Cheng, Shih-Lung
    Lin, Shu-Min
    Peng, Chung-Kan
    Chan, Ming-Cheng
    Shen, Sheng-Yeh
    Kuo, Ping-Hung
    Lai, Chien-Hao
    Lan, Chou-Chin
    Chen, Chung-Yu
    Lin, Ching-Hsiung
    Liao, Kuang-Ming
    Feng, Po-Hao
    Wu, Jiin-Torng
    Wei, Yu-Feng
    Xu, Xiaomeng
    Alfonso-Christancho, Rafael
    Lai, Tina
    Navarro, Aldo
    Milea, Dominique
    Perng, Diahn-Warng
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2025, 19
  • [26] Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months
    Kayser, Moritz Z.
    Drick, Nora
    Milger, Katrin
    Fuge, Jan
    Kneidinger, Nikolaus
    Korn, Stephanie
    Buhl, Roland
    Behr, Juergen
    Welte, Tobias
    Suhling, Hendrik
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 863 - 871
  • [27] Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
    Portacci, Andrea
    Campisi, Raffaele
    Buonamico, Enrico
    Nolasco, Santi
    Pelaia, Corrado
    Crimi, Nunzio
    Benfante, Alida
    Triggiani, Massimo
    Spadaro, Giuseppe
    Caiaffa, Maria Filomena
    Scioscia, Giulia
    Detoraki, Aikaterini
    Valenti, Giuseppe
    Papia, Francesco
    Tomasello, Alessandra
    Scichilone, Nicola
    Pelaia, Girolamo
    Crimi, Claudia
    Carpagnano, Giovanna Elisiana
    ERJ OPEN RESEARCH, 2023, 9 (05)
  • [28] Real-world clinical remission of severe asthma with benralizumab in Spanish adults with severe asthma
    Martinez-Moragon, Eva
    Chiner, Eusebi
    Mogrovejo, Alexandra Suliana
    Cervera, Marta Palop
    Tortajada, Inmaculada Lluch
    Enrique, Ignacio Boira
    Vera, Andres Fernando Sanchez
    JOURNAL OF ASTHMA, 2024, 61 (10) : 1190 - 1204
  • [29] Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab
    Walsh, Laura J.
    Casey, Deborah
    Vairamani, Punitha
    Arnott, Fiona
    Plant, Barry J.
    Murphy, Desmond M.
    FRONTIERS IN ALLERGY, 2023, 3
  • [30] Real-world Effectiveness of Mepolizumab in Reducing Asthma Exacerbations in Japan
    Nagase, H.
    Tamaoki, J.
    Suzuki, T.
    Nezu, Y.
    Akiyama, S.
    Cole, A.
    Yang, S.
    Mu, G.
    Katsumata, M.
    Komatsubara, M.
    Cristancho, R. Alfonso
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)